Guided antiplatelet therapy with P2Y12 antagonists in patients undergoing percutaneous coronary intervention: 3 systematic reviews with meta-analyses of randomized controlled trials with homogeneous design
Simone Birocchi, Matteo Rocchetti, Alessandro Minardi, Gian Marco Podda, View ORCID ProfileAlessandro Squizzato, View ORCID ProfileMarco Cattaneo
doi: https://doi.org/10.1101/2023.05.25.23290520
Simone Birocchi
1Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
Matteo Rocchetti
2Divisione di Cardiologia, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
Alessandro Minardi
2Divisione di Cardiologia, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
Gian Marco Podda
1Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
Alessandro Squizzato
3Research Center on Thromboembolic Disorders and Antithrombotic Therapies, ASST Lariana, University of Insubria, Como, Italy
Marco Cattaneo
1Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy
4Università degli Studi di Milano, Milan, Italy
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted May 29, 2023.
Guided antiplatelet therapy with P2Y12 antagonists in patients undergoing percutaneous coronary intervention: 3 systematic reviews with meta-analyses of randomized controlled trials with homogeneous design
Simone Birocchi, Matteo Rocchetti, Alessandro Minardi, Gian Marco Podda, Alessandro Squizzato, Marco Cattaneo
medRxiv 2023.05.25.23290520; doi: https://doi.org/10.1101/2023.05.25.23290520
Guided antiplatelet therapy with P2Y12 antagonists in patients undergoing percutaneous coronary intervention: 3 systematic reviews with meta-analyses of randomized controlled trials with homogeneous design
Simone Birocchi, Matteo Rocchetti, Alessandro Minardi, Gian Marco Podda, Alessandro Squizzato, Marco Cattaneo
medRxiv 2023.05.25.23290520; doi: https://doi.org/10.1101/2023.05.25.23290520
Subject Area
Subject Areas
- Addiction Medicine (329)
- Allergy and Immunology (648)
- Anesthesia (173)
- Cardiovascular Medicine (2484)
- Dermatology (209)
- Emergency Medicine (384)
- Epidemiology (11947)
- Forensic Medicine (10)
- Gastroenterology (714)
- Genetic and Genomic Medicine (3874)
- Geriatric Medicine (358)
- Health Economics (648)
- Health Informatics (2503)
- Health Policy (963)
- Hematology (350)
- HIV/AIDS (812)
- Medical Education (384)
- Medical Ethics (106)
- Nephrology (411)
- Neurology (3638)
- Nursing (204)
- Nutrition (542)
- Oncology (1887)
- Ophthalmology (549)
- Orthopedics (229)
- Otolaryngology (298)
- Pain Medicine (240)
- Palliative Medicine (71)
- Pathology (459)
- Pediatrics (1066)
- Primary Care Research (434)
- Public and Global Health (6305)
- Radiology and Imaging (1335)
- Respiratory Medicine (845)
- Rheumatology (388)
- Sports Medicine (333)
- Surgery (424)
- Toxicology (51)
- Transplantation (179)
- Urology (152)